NG144 Cannabis-based medicinal products
This NICE guideline was published in November 2019 and covers the prescribing of cannabis-based medicinal products for people with intractable nausea and vomiting, chronic pain, spasticity and severe treatment-resistant epilepsy.
It makes five recommendations on:
- Intractable nausea and vomiting
- Chronic pain
- Severe treatment-resistant epilepsy